title: [H2-blockers of histamine receptors in the therapy of early stages of gastroduodenal reflux disease].
abstract: The efficacy of the administration of famotidine, 20 mg BID, at early stages of gastroduodenal reflux disease (GDRD) based on a clinical and endoscopy study and treatment of patients of 0 and 1 degrees on the modified Savary-Miller scale.
authors.forename: L B
authors.initials: LB
authors.lastname: Lazebnik
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Vasil'ev
authors.forename: A A
authors.initials: AA
authors.lastname: Masharova
authors.forename: S A
authors.initials: SA
authors.lastname: Zelenkin
authors.forename: O B
authors.initials: OB
authors.lastname: Ianova
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D004383:Duodenogastric Reflux / Q000175:diagnosis / Q000188:drug therapy*; D016099:Endoscopy, Gastrointestinal; D015738:Famotidine / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D006635:Histamine H2 Antagonists; D015738:Famotidine